President Trump announced that nine additional pharmaceutical manufacturers have agreed to most favored nation (MFN) pricing agreements. These companies include Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB. During the press conference, President Trump once again called upon Congress to codify the MFN agreements so that they may remain permanent under future presidencies…. (Slifer, August 31, 2026) #Drug Pricing, #Prescription Drugs